Celloid is a biopharma and biotechnology startup that was founded in 2021. The company recently received a KRW2.40B seed round investment on 31 January 2024. The investment was made by FuturePlay and POSTECH Holdings. With a focus on these innovative industries, Celloid is positioned to make a significant impact in the biotech and pharmaceutical sectors. This latest investment demonstrates confidence from prominent investors and signals a promising future for the company.
Celloid
Founded 2021
Seed
Total: $2.40B
Biopharma, Biotechnology
General Information
Company Name
Celloid
Founded Year
2021
Industries
Biopharma, Biotechnology
Funding Stage
Seed
BounceWatch is an independent company data service, not affiliated with Celloid. To contact Celloid, visit celloid.co.kr.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
About Celloid
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | KRW2.40B | 2 |
|
31 Jan 2024 |
| Seed Round | Undisclosed | 1 |
|
01 Jun 2022 |
FAQ About Celloid
Celloid was founded in 2021.
Celloid operates in Biopharma and Biotechnology.
Celloid has completed 2 funding rounds, raising a total of $2.40B. The latest funding stage is Seed.
We're actively collecting intelligence on Celloid.
Source: BounceWatch company record for Celloid, https://bouncewatch.com/company/celloid, updated 12 September 2024. When citing, please name BounceWatch and link this page.
